FDA Letter API

Dairy Feeds, Inc.

Letter data

Company
Dairy Feeds, Inc.
Recipient
Ms. Brenda Godwin | General Manager | Dairy Feeds, Inc. | P.O. Box 1365 | Okeechobee | , | FL | 34973-1365 | United States | dairyfeeds@embarqmail.com
Issue date
2024-07-08
Posted date
Not available
FDA office
Division of Human and Animal Food Operations East IV
Subject
Not available
Product
Animal & Veterinary
CMS ID
625951
Reference number
24-HAFE4-WLCOL-07
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Dairy Feeds, Inc. MARCS-CMS 625951 — July 08, 2024 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Reference #: 24-HAFE4-WLCOL-07 Product: Animal & Veterinary Recipient: Recipient Name Ms. Brenda Godwin Recipient Title General Manager Dairy Feeds, Inc. P.O. Box 1365 Okeechobee , FL 34973-1365 United States dairyfeeds@embarqmail.com Issuing Office: Division of Human and Animal Food Operations East IV United States Secondary Issuing Offices United States Dear Ms. Brenda Godwin: The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter, 22-HAFE4-WL-06, dated July 27, 2022. Based on our evaluation It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Pearl E. Lopina -S Pearl Lopina Director of Compliance Branch Content current as of: 07/17/2024 Regulated Product(s) Animal & Veterinary